is jardiance a glp 1 (empagliflozin) sodium‑glucose cotransporter‑2 (SGLT‑2) inhibitor or a glucagon‑like peptide‑1 (GLP‑1) receptor agonist? jardiance vs glp 1 Effect
Description
So the abdomen wins on paper, but rotating between all three sites is better for your tissue long-term than staying fixed to one location
Because these drugs are still so new, theres no longitudinal data on how they affect eating disorders in the long term
That discontinuation rate is remarkably low for this class of drugs
doi: 10.3390/ijms22031273 [DOI] [PMC free article] [PubMed] [Google Scholar] 41
They are named with the suffix -tide , and include exenatide, liraglutide, dulaglutide, semaglutide and tirzepatide
Where on the body would it be applied
